Steve holds a PhD in Biochemistry from the Faculty of Medicine at the University of Toronto, Canada. He worked as a medical scientist for 18 years, within both industry and academia, where his research focused on the discovery of new medicines to treat inflammatory disorders and infectious diseases. Steve recently stepped away from the lab and into science communications, where he’s helping make medical science information more accessible for everyone.
Low levels of the blood clotting factor fibrinogen in adults with secondary hemophagocytic lymphohistiocytosis (sHLH) are linked to an increased risk of mortality, a study suggested. That finding supports fibrinogen’s potential ... Read more
The anti-cancer medicine ruxolitinib was successfully used to treat a boy with hemophagocytic lymphohistiocytosis (HLH) who was unable to receive immunosuppressant therapies due to a viral infection, a case study ... Read more
A previously unknown mutation in a protein that regulates immune activation, called Roquin-1, was found to be the underlying cause of uncontrolled cytokine release and excessive inflammation — hallmarks of ... Read more